Literature DB >> 32981641

Socioeconomic Status, Health Care, and Outcomes in Systemic Lupus Erythematosus.

Kimberly DeQuattro1, Edward Yelin2.   

Abstract

Systemic lupus erythematosus (SLE) disproportionately affects those with low socioeconomic status. Evidence from the past 2 decades has revealed clearer distinctions on the mechanisms of poverty that affect long-term outcomes in SLE. Poverty exacerbates direct, indirect, and humanistic costs and is associated with worse SLE disease damage, greater mortality, and poorer quality of life. Ongoing commitments from medicine and society are required to reduce disparities, improve access to care, and bolster resilience in persons with SLE who live in poverty.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Outcomes; Poverty; Socioeconomic status; Systemic lupus erythematosus

Year:  2020        PMID: 32981641     DOI: 10.1016/j.rdc.2020.07.004

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  4 in total

Review 1.  Integrating genetic and social factors to understand health disparities in lupus.

Authors:  Paula S Ramos
Journal:  Curr Opin Rheumatol       Date:  2021-11-01       Impact factor: 4.941

2.  The predictive value of fibrinogen-to-albumin ratio in the active, severe active, and poor prognosis of systemic lupus erythematosus: A single-center retrospective study.

Authors:  Lu-Lu Dai; Cheng Chen; Jie Wu; Jin-Feng Cheng; Feng He
Journal:  J Clin Lab Anal       Date:  2022-07-23       Impact factor: 3.124

Review 3.  State of the art and future directions in assessing the quality of life in rare and complex connective tissue and musculoskeletal diseases.

Authors:  Leopoldo Trieste; Sara Cannizzo; Ilaria Palla; Isotta Triulzi; Giuseppe Turchetti
Journal:  Front Med (Lausanne)       Date:  2022-09-23

Review 4.  Patient-Reported Outcomes in Systemic Lupus Erythematosus. Can Lupus Patients Take the Driver's Seat in Their Disease Monitoring?

Authors:  Ioannis Parodis; Paul Studenic
Journal:  J Clin Med       Date:  2022-01-11       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.